ClinicalTrials.govpublic full text
GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
atrial fibrillation, atrial fibrillation,atrial remodeling,dysrhythmias,valsartan, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 844061
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.